Dexcom Inc reports results for the quarter ended December 31 - Earnings Summary

• Dexcom Inc DXCM.OQ reported quarterly adjusted earnings of 45 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 50 cents. The mean expectation of twenty two analysts for the quarter was for earnings of 50 cents per share. Wall Street expected results to range from 41 cents to 59 cents per share.

• Revenue rose 7.6% to $1.11 billion from a year ago; analysts expected $1.10 billion.

• Dexcom Inc's reported EPS for the quarter was 38 cents​.

• The company reported quarterly net income of $151.7 million.

• Dexcom Inc shares had risen by 7.8% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 3.9% in the last three months.​

• In the last 30 days, six analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Dexcom Inc is $99.00

This summary was machine generated from LSEG data February 13 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)